Direct listing Completed

Polaryx Therapeutics direct listing

Announced 29 Jan 2026 · NASDAQ: PLYX

Advisers

Polaryx Therapeutics

Issuer

Financial adviser

Lead managers

Not disclosed

Issuer
Polaryx Therapeutics
Issuer based in
United States
Completed
2 Feb 2026
Sector
Biotech
Tags
Biotech, Rare Disease

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.